Equities
  • Price (USD)8.52
  • Today's Change-0.90 / -9.55%
  • Shares traded132.86k
  • 1 Year change-52.87%
  • Beta--
Data delayed at least 15 minutes, as of Feb 13 2026 20:58 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
6869:TYO since
announced
Transaction
value
JEOL Ltd-Medical Equipment BusinessAnnounced02 Sep 202502 Sep 2025Announced-31.58%--
Data delayed at least 15 minutes, as of Feb 17 2026 02:30 GMT.

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Sterling Capital Management LLCas of 31 Dec 202542.28k0.01%
RhumbLine Advisers LPas of 31 Dec 202520.46k0.00%
PNC Wealth Management LLCas of 31 Dec 20257.32k0.00%
BlackRock Advisors LLCas of 05 Feb 20265.87k0.00%
GAMMA Investing LLCas of 31 Dec 20253.29k0.00%
ShariaPortfolio, Inc.as of 05 Feb 20263.02k0.00%
Salomon & Ludwin LLCas of 31 Dec 2025379.000.00%
Hantz Financial Services, Inc.as of 31 Dec 2025229.000.00%
Copeland Capital Management LLCas of 31 Dec 2025141.000.00%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.